ArticleEJNMMI research2017
O-(2-[
Article in EJNMMI research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 25 citations in OpenAlex.
- Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.Neuro-oncology · 2019Trial
- Reconstruction matters: influence of EARL standards and BSREM in [EJNMMI research · 2026Article
- Characteristics of [European journal of nuclear medicine and molecular imaging · 2026Article
- Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation.European journal of nuclear medicine and molecular imaging · 2026Article
- Feasibility of different meningioma delineation approaches on [Discover oncology · 2025Article
- Feasibility of different lymph node metastases delineation approaches in [EJNMMI reports · 2025Article
- The role of FET-PET in patient selection and response assessment for reirradiation in recurrent glioblastoma.Frontiers in oncology · 2025Review
- Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.Neuro-oncology · 2024Review
- Impact of improved dead time correction on the quantification accuracy of a dedicated BrainPET scanner.PloS one · 2024Article
- Comparison between [International journal of molecular sciences · 2023Article
- Boosting the acceptance ofEuropean journal of nuclear medicine and molecular imaging · 2023Article
- Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.Journal of neuro-oncology · 2021Article
- Feasibility of Different Tumor Delineation Approaches forFrontiers in oncology · 2021Article
- Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[European journal of nuclear medicine and molecular imaging · 2020Article
- Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [European journal of nuclear medicine and molecular imaging · 2019Article
- Predicting IDH genotype in gliomas using FET PET radiomics.Scientific reports · 2018Article
- Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.PloS one · 2018Article
- Utility of dynamicNeuro-oncology advancesArticle
- Multi-threshold volumetricNeuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPET using O-(2-[
resultsSignificant differences between centres A and B were found especially for TBR
conclusionsVariable data processing of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.